CONTACT US NEXALIS THERAPEUTICS T: +61 3 9070 1221 | E: investors@nexalistherapeutics.com | W: https://www.nexalistherapeutics.com 1 02 October 2026 Melbourne, Australia – Nexalis Therapeutics Ltd (ASX: NX1) (Nexalis, NX1 or the Company) advises that Mr Sean Williams has resigned as...
Chair Appointment/Resignation
Filed with ASX ·
6ix hasn’t read this filing yet.
Nexalis Therapeutics Limited on 6ix
Earlier from Nexalis Therapeutics
- Removal of draft wording in the directors report HY accounts
- Half Yearly Report and Accounts
- Jun26 Appendix 4C Cash Flow Report
- Jun26 Quarterly Activities Report
- Change in substantial holding
Later from Nexalis Therapeutics
- Initial Director's Interest Notice - Niv Dagan
- Final Director's Interest Notice - Sean Williams
- Change of Director's Interest Notice - Darryl Davies
- Notification of cessation of securities - NX1
- Proposed issue of securities - NX1
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics